EPOFIT 10000

Epofit 10000IU Injection contains the active substance epoetin alfa, a man-made form of erythropoietin, which is a hormone that stimulates the bone marrow to produce red blood cells. It is primarily used to manage anemia related to chronic kidney disease, cancer chemotherapy, or HIV treatment with zidovudine. It may also be used to minimize the need for blood transfusions in patients undergoing surgery where blood loss is expected.

This medication should be avoided in individuals with known hypersensitivity to epoetin alfa or any of its ingredients. It is contraindicated in patients with uncontrolled hypertension, thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA) following ESA therapy, or those experiencing active seizures. Use during pregnancy and breastfeeding is not recommended unless clearly necessary, and only under strict medical supervision.

Caution is advised in individuals with cardiovascular conditions such as previous heart attacks, strokes, or clotting disorders, as epoetin alfa may increase the risk of thromboembolic events. It must also be administered with care in patients with liver disorders, blood cell abnormalities like thalassemia or sickle cell disease, and hematological malignancies. For pediatric and elderly patients, close clinical monitoring is important to minimize risks and ensure appropriate therapeutic outcomes.

Always discuss your complete medical history and any current medications with your doctor before starting Epofit 10000IU, so that treatment can be tailored safely to your condition.